PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1973 September; 66(9): 897–900.
PMCID: PMC1645430

Drug-induced nephropathies.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (729K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet. 1973 Feb 10;1(7798):275–280. [PubMed]
  • ANGERVALL L, LEHMANN L, BENGTSSON U. THE RENAL CONCENTRATING CAPACITY IN ALBINO RATS AFTER LONG-TERM CONSUMPTION OF PHENACETIN, NAPA (N-ACETYL-P-AMINOPHENOL) AND ACETYLSALICYLIC ACID. Acta Med Scand. 1964 Feb;175:155–160. [PubMed]
  • Bengtsson U, Angervall L, Ekman H, Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol. 1968;2(3):145–150. [PubMed]
  • Brown DM, Hardy TL. Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother. 1968 Jan;32(1):17–24. [PubMed]
  • BRUN C, OLSEN S, RAASCHOU F, SORENSEN AW. THE LOCALIZATION OF GOLD IN THE HUMAN KIDNEY FOLLOWING CHRYSOTHERAPY: A BIOPSY STUDY. Nephron. 1964;1:265–276. [PubMed]
  • Bulger RJ, Healey LA, Polinsky P. Renal abnormalities in rheumatoid arthritis. Ann Rheum Dis. 1968 Jul;27(4):339–344. [PMC free article] [PubMed]
  • Burry AF. A profile of renal disease in Queensland: results of an autopsy survey. Med J Aust. 1966 May 14;1(20):826–834. [PubMed]
  • Burry AF. The evolution of analgesic nephropathy. Nephron. 1968;5(3):185–201. [PubMed]
  • Burry HC. Reduced glomerular function in rheumatoid arthritis. Ann Rheum Dis. 1972 Jan;31(1):65–68. [PMC free article] [PubMed]
  • Burry HC. Bacteriuria in rheumatoid arthritis. Ann Rheum Dis. 1973 May;32(3):208–211. [PMC free article] [PubMed]
  • DEROT M, KAHN J, MAZALTON A, PEYRAFORT J. Néphrite anurique aiguë mortelle après traitement aurique, chrysocyanose associée. Bull Mem Soc Med Hop Paris. 70(7-8):234–239. [PubMed]
  • DUTHIE JJ, BROWN PE, TRUELOVE LH, BARAGAR FD, LAWRIE AJ. COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis. 1964 May;23:193–204. [PMC free article] [PubMed]
  • Fairley KF, Kincaid-Smith P. Renal papillary necrosis with a normal pyelogram. Br Med J. 1968 Jan 20;1(5585):156–157. [PMC free article] [PubMed]
  • Felts JH, King JS, Boyce WH. Nephrotic syndrome after treatment with D-penicillamine. Lancet. 1968 Jan 6;1(7532):53–54. [PubMed]
  • Fraser TN. Gold Treatment in Rheumatoid Arthritis. Ann Rheum Dis. 1945 Jun;4(4):71–75. [PMC free article] [PubMed]
  • Freyberg RH, Block WD, Levey S. Metabolism, Toxicity and Manner of Action of Gold Compounds used in the Treatment of Arthritis: Complete Excretion Studies and Comparison of Intravenous and Intramuscular administration of Some Gold Salts. Ann Rheum Dis. 1942 Dec;3(2):77–89. [PMC free article] [PubMed]
  • Hándlová D. Ledvinové komplikace lécby zlatem u progresivní polyartritidy. Vnitr Lek. 1968 Feb;14(2):115–118. [PubMed]
  • HEIDELMANN G, HUTH J, KOCH E. Uber Nierenfunktionsstörungen bei chronischer Polyarthritis. Z Rheumaforsch. 1956 Aug;15(7-8):208–219. [PubMed]
  • Huskisson EC, Hart FD. Penicillamine in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1972 Sep;31(5):402–404. [PMC free article] [PubMed]
  • Jaffe IA. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthritis Rheum. 1965 Dec;8(6):1064–1079. [PubMed]
  • Jaffe IA, Treser G, Suzuki Y, Ehrenreich T. Nephropathy induced by D-penicillamine. Ann Intern Med. 1968 Sep;69(3):549–556. [PubMed]
  • Kennedy A, Saluga PG. Urinary cytology in experimental toxic renal injury. Ann Rheum Dis. 1970 Sep;29(5):546–552. [PMC free article] [PubMed]
  • Kincaid-Smith P. Analgesic nephropathy and papillary necrosis. Postgrad Med J. 1968 Oct;44(516):807–810. [PMC free article] [PubMed]
  • Krikler DM. Paracetamol and the kidney. Br Med J. 1967 Jun 3;2(5552):615–616. [PMC free article] [PubMed]
  • Lawson AA, Maclean N. Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis. 1966 Sep;25(5):441–449. [PMC free article] [PubMed]
  • Leathwood PD, Plummer DT. The excretion of lacate dehydrogenase in human urine after he ingestion of aspiin. Biochem J. 1969 Sep;114(2):197–202. [PubMed]
  • LEE JC, DUSHKIN M, EYRING EJ, ENGLEMAN EP, HOPPER J., Jr RENAL LESIONS ASSOCIATED WITH GOLD THERAPY; LIGHT AND ELECTRON MICROSCOPIC STUDIES. Arthritis Rheum. 1965 Feb;8:1–13. [PubMed]
  • PRESCOTT LF. EFFECTS OF ACETYLSALICYLIC ACID, PHENACETIN, PARACETAMOL, AND CAFFEINE ON RENAL TUBULAR EPITHELIUM. Lancet. 1965 Jul 17;1(7403):91–95. [PubMed]
  • RICHARDSON JH, ALDERFER HH. Acute renal failure caused by phenylbutazone. N Engl J Med. 1963 Apr 11;268:809–811. [PubMed]
  • Saker BM, Kincaid-Smith P. Papillary necrosis in experimental analgesic nephropathy. Br Med J. 1969 Jan 18;1(5637):161–162. [PMC free article] [PubMed]
  • Sänger L, Stoeber E, Kölle G. Langzeittherapie mit Indometacin bei der juvenilen rheumatoiden Arthritis und beim Morbus Still. Arzneimittelforschung. 1967 Nov;17(11):1414–1420. [PubMed]
  • SCHNITZER B, SMITH EB, GOLDEN A. THE EFFECTS OF PHENACETIN AND ITS CONTAMINANT ON THE KIDNEY OF THE RAT. Am J Pathol. 1965 Jun;46:917–927. [PubMed]
  • Shelley JH. Phenacetin, through the looking glass. Clin Pharmacol Ther. 1967 May-Jun;8(3):427–471. [PubMed]
  • Silverberg DS, Kidd EG, Shnitka TK, Ulan RA. Gold nephropathy. A clinical and pathologic study. Arthritis Rheum. 1970 Nov-Dec;13(6):812–825. [PubMed]
  • SORENSEN AW. THE KIDNEY FUNCTION IN RELATION TO DRUG CONSUMPTION IN PATIENTS WITH RHEUMATOID ARTHRITIS. (V). Acta Rheumatol Scand. 1963;9:122–140. [PubMed]
  • Steele TW, Györy AZ, Edwards KD. Renal function in analgesic nephropathy. Br Med J. 1969 Apr 26;2(5651):213–216. [PMC free article] [PubMed]
  • Stoeber E, Sänger L, Kölle G. Indometacin-Behandlung der juvenilen rheumatoiden Arthritis (chronische Polyarthritis) Munch Med Wochenschr. 1968 Mar 1;110(9):548–551. [PubMed]
  • Thomas JP, Coles GA, el-Shaboury AH. Nocturia in patients on long-term steroid therapy. Clin Sci. 1970 Apr;38(4):415–425. [PubMed]
  • THURAU K. RENAL HEMODYNAMICS. Am J Med. 1964 May;36:698–719. [PubMed]
  • WALSHE JM. Wilson's disease; new oral therapy. Lancet. 1956 Jan 7;270(6906):25–26. [PubMed]
  • Wilkinson R, Eccleston DW. Nephrotic syndrome induced by gold therapy. Br Med J. 1970 Jun 27;2(5712):772–772. [PMC free article] [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press